New therapeutic target in inflammatory disease: Macrophage migration inhibitory factor

Internal Medicine Journal

Volumn 35, Issue 7, 2005, Pages 419-426

  Morand, Eric F ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Glucocorticoids; Inflammation; Macrophage migration inhibitory factor; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROMA; CANCER; CELL PROLIFERATION; CELLULAR IMMUNITY; COLITIS; DRUG TARGETING; ENDOTHELIUM CELL; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BIOLOGICAL MARKERS; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS;

EID: 21444458313     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00853.x     Document Type: Review

References (85)

1. David J. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72-7.
2. Nathan CF, Remold HG, David JR. Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med 1973; 137: 275-90.
3. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-902.
4. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756-9.
5. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377; 68-71.
6. Leech M, Metz CN, Smith M, Weedon H, Holdsworth SR, Bucala R et al. Macrophage migration inhibitory factor (MIF) in rheumatoid arthritis: evidence for pro-inflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42: 1601-8.
7. Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in automne and paracrine fashion. Immunology 1997; 92: 131-7.
8. Froidevaux C, Roger T, Martin C, Glauser MP, Calandra T. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med 2001; 29 (7 Suppl): S13-15.
9. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WAH, Metz CN et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320-23.
10. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002; 99: 345-50.
11. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849-54.
12. Altboum I, Pick E. Antigen and mitogen induced production of macrophage migration inhibitory factor in the mouse. Int Arch Allergy Appl Immunol 1979; 60: 29-43.
13. Sorg C. Characterization of murine macrophage migration inhibitory activities (MIF) released by concanavalin A stimulated thymus or spleen cells. Mol Immunol 1980; 17: 565-9.
14. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996; 183: 277-82.
15. Santos LL, Hall P, Metz CN, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001; 123: 309-14.
16. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998; 10: 199-205.
17. Yang Y, Degranpre P, Kharfi A, Akoum A. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 2000; 85: 4721-7.
18. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999; 5: 181-91.
19. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma J Clin Invest 1998; 101: 2869-74.
20. Wymann D, Bluggel M, Kalbacher H, Blesken T, Akdis CA, Meyer HE et al. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif. Immunology 1999; 96: 1-9.
21. Wahl SM, Iverson GM, Oppenheim JJ. Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med 1974; 140: 1631-45.
22. Takahashi K, Kato Y, Sugiyama T, Koide N, Kawai M, Fukada M et al. Production of murine collagen-induced arthritis using Klebsiella pneumoniae O3 lipopolysaccharide as a potent immunological adjuvant. Microbiol Immunol 1999; 43: 795-801.
23. Cunha FQ, Weiser WY, David JR, Moss DW, Moncada S, Liew FY. Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol 1993; 150: 1908-12.
24. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33: 14144-55.
25. Bozza M, Satoskar AB, Lin G, Lu B, Humbles AA, Gerard C et al. Targeted disruption of Migration Inhibitory Factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341-6.
26. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414: 920-4.
27. de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061-6.
28. Wu JY, Cunha FQ, Liew FY, Weiser WY. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 1993; 151: 4325-32.
29. Gregory JL, Leech MT, David JR, Yang YH, Dacumos A, Hickey MJ. Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum 2004; 50: 3023-34.
30. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999; 11: 163-7.
31. Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002; 41: 558-62.
32. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001; 44: 1273-80.
33. Santos L, Lacey DC, Yang Y, Leech M, Morand EF. Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor (MIF). J Rheumatol 2004; 31: 1038-43.
34. Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum 2004; 50: 1437-47.
35. Lacey DC, Sampey AV, Mitchell R, Bucala R, Santos L, Leech M et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor (MIF). Arthritis Rheum 2003; 48: 103-9.
36. Leech M, Lacey DC, Xue JR, Santos L, Hutchinson P, Wolvetang E et al. Macrophage migration inhibitory factor (MIF) regulates p53 in inflammatory arthritis. Arthritis Rheum 2003; 48: 1881-9.
37. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275: 444-50.
38. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997; 158: 5514-17.
39. Leech M, Santos LL, Metz C, Holdsworth SR, Bucala R, Morand EF. Control of macrophage migration inhibitory factor (MIF) by endogenous glucocorticoids in rat adjuvant arthritis. Arthritis Rheum 2000; 43: 827-33.
40. Leech M, Metz CN, Santos LL, Peng T, Holdsworth SR, Bucala R et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998; 41: 910-17.
41. Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A et al. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004; 26: 187-94.
42. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
43. Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002; 123: 256-70.
44. Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31: 337-43.
45. Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease. J Neurol Sci 2000; 179: 127-31.
46. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 2003; 170: 1274-82.
47. Steinhoff M, Meinhardt A, Steinhoff A, Gemsa D, Bucala R, Bacher M. Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease. Br J Dermatol 1999; 141: 1061-6.
48. Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H et al. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 2001; 116: 989-90.
49. Lan HY, Mu W, Yang NS, Meinhardt A, Nikolicpaterson DJ, Ng YY et al. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996; 149: 1119-27.
50. Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, Metz C et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997; 185: 1455-65.
51. Yang NS, Nikolic-Paterson DJ, Ng YY, Mu W, Metz C, Bacher M et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF) - potential role of MIF in regulating glucocorticoid production. Mol Med 1998; 4: 413-24.
52. Taniguchi Y, Yorioka N, Yamashita K, Masaki T, Yamakido M. Macrophage migration inhibitory factor in IgA nephropathy. Kidney Int 1998; 54: 2245-6.
53. Rice EK, Nikolic-Paterson DJ, Hill PA, Metz CN, Bucala R, Atkins RC et al. Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells. Nephrology (Carlton) 2003; 8: 156-61.
54. Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 2002; 13 (Suppl 1): S7-13.
55. Brown FG, Nikolic-Paterson DJ, Chadban SJ, Dowling J, Jose M, Metz CN et al. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation 2001; 71: 1777-83.
56. Hoi A, Morand EF, Leech M. Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 2003; 81: 367-73.
57. Rovensky J, Svejcar J, Pekarek J, Zitnan D, Hajzok O, Cebecauer L. Correlation between the results of the migration inhibitory factor production test with DNA and the severity of the disease in the systemic lupus erythematosus patients. Z Immunitatsforsch Exp Klin Immunol 1975; 150: 24-30.
58. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000; 5: 397-403.
59. Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004; 31: 268-73.
60. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57: 499-509.
61. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 2000; 87: 1202-8.
62. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, Dimmeler S et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002; 105: 1561-6.
63. Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu H et al. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2004; 109: 3149-53.
64. Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, Fingerle-Rowson G et al. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 2005; 178: 207-15.
65. Shimizu T, Nishihira J, Watanabe H, Abe R, Honda A, Ishibashi T et al. Macrophage migration inhibitory factor (MIF) is induced by thrombin and factor Xa in endothelial cells. J Biol Chem 2004; 279: 13729-37.
66. Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L et al. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 709-14.
67. Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 2004; 109: 380-85.
68. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNAs during adjuvant-induced arthritis in the rat. J Mol Endocrinol 1992; 9: 273-81.
69. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997; 24: 1758-64.
70. Morand EF, Cooley H, Leech M, Littlejohn GO. Advances in the understanding of neuroendocrine function in rheumatic disease. Aust N Z J Med 1996; 26: 543-57.
71. Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003; 162: 47-56.
72. Petrovsky N, Bucala R. Macrophage migration inhibitory factor: a critical neurohumoral mediator. Front Horm Res 2002; 29: 83-90.
73. Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997; 94: 4782-7.
74. Vedder H, Krieg J, Gerlach B, Gemsa D, Bacher M. Expression and glucocorticoid regulation of macrophage migration inhibitory factor (MIF) in hippocampal and neocortical rat brain cells in culture. Brain Res 2000; 869: 25-30.
75. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42: 1601-8.
76. Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H. Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 2005; 146: 1006-11.
77. Tierney T, Patel R, Stead CA, Leng L, Bucala R, Buckingham JC. Macrophage migration inhibitory factor is released from pituitary folliculo-stellate-like cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition of interleukin 6 release. Endocrinology 2005; 146: 35-43.
78. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002; 277: 7865-74.
79. Onodera S, Nishihira J, Yamazaki M, Ishibashi T, Minami A. Increased expression of macrophage migration inhibitory factor during fracture healing in rats. Histochem Cell Biol 2004; 121: 209-17.
80. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-76.
81. Philo JS, Yang TH, LaBarre M. Re-examining the oligomerization state of macrophage migration inhibitory factor (MIF) in solution Biophys Chem 2004; 108: 77-87.
82. Zhang M, Aman P, Grubb A, Panagopoulos I, Hindemith A, Rosengren E et al. Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Lett 1995; 373: 203-6.
83. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN et al. The immunoregulatory mediator macrophage migration inhibitory factor (mif) catalyzes a tautomerization reaction Mol Med 1996; 2: 143-9.
84. Orita M, Yamamoto S, Katayama N, Aoki M, Takayama K, Yamagiwa Y et al. Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography. J Med Chem 2001; 44: 540-47.
85. Dios A, Mitchell RA, Aljabari B, Lubetsky J, O'Connor K, Liao H et al. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. J Med Chem 2002; 45: 2410-16.